Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy

Abstract The aim of the present study was to investigate the usefulness of multidrug resistance protein 1 (MDR1) and neuropeptide Y (NPY) levels in predicting the efficacy of levetiracetam (LEV) plus oxcarbazepine (OXC) treatment administered to children with epilepsy and to determine their prognosis. Overall, 193 children with epilepsy admitted to the hospital were enrolled and randomly divided into two groups according to different treatment methods: group A (n = 106, treated with LEV plus OXC combination) and group B (n = 87, treated with OXC only). After treatment, compared with group B, group A exhibited a remarkably higher total effective rate and a significantly lower total adverse reaction rate. Areas under the curve for MDR1 and NPY for predicting ineffective treatment were 0.867 and 0.834, whereas those for predicting epilepsy recurrence were 0.916 and 0.829, respectively. Electroencephalography abnormalities, intracranial hemorrhage, neonatal convulsion, premature delivery, and MDR1 and NPY levels were independent risk factors for poor prognosis in children with epilepsy. Serum MDR1 and NPY levels exhibited a high predictive value for early epilepsy diagnosis, treatment efficacy assessment, and prognostication in children with epilepsy treated with LEV plus OXC combination.

Simultaneous Estimation and Validation of Four Antiepileptic Drugs from Bulk and Formulations Using Reverse Phase HPLC

Abstract Epilepsy is a disorder of the central nervous system, in which the nerve cell activity in the brain is disturbed causing seizures. The objective was to develop an RP-HPLC method for consistent simultaneous quantitation of four antiepileptic drugs Levetiracetam (LVT), Lamotrigine (LTG), Phenobarbital (PBT) and Phenytoin (PTY). An isocratic method was developed on C18 column in JASCO HPLC using 5 mM potassium phosphate buffer (pH 6) and acetonitrile as the mobile phase at a flow rate of 1ml/min and detected at 230 nm using UV detector. The mean retention time for LVT, LTG, PBT and PTY were found as 2.55, 3.55, 4.65 and 5.99 minutes respectively. The method was validated as per ICH guidelines and was found to be acceptable. The %RSD value was <2.0 % thus stating the developed method was precise for the drugs in the given range. The accuracy values were within 85-115% of the recovery range. The specificity of the method was evaluated by an assay of marketed formulation, and it showed a percent content between 90-110% w/w for all the four drugs. The proposed analytical method was simple, accurate and robust and was precisely able to resolve the four major antiepileptic drugs. Hence, the current method can be applied successfully for routine examination of these drugs

The antiepileptic activity of Safranal in kindling model of epilepsy in male rats

Abstract Recent studies suggested that safranal exerts anticonvulsant properties. The present study aimed to investigate the effect of safranal on epileptic activities in the amygdala electrical kindling model in male rats. Animals were implanted with a recording electrode on the skull and a tripolar in the amygdala. After 10 days of recovery, the afterdischarge (AD) threshold of each animal was determined and stimulated once daily the AD threshold for full kindling development. Then, parameters including afterdischarge duration (ADD), stage 4 latency (S4L), stage 5 duration (S5D), and stimulation threshold were determined before and after injection of safranal (0.05, 0.1, 0.2 ml/ kg; i.p). While the dose of 0.05 ml/kg had no significant effect, the dose of 0.1 ml/kg increased the AD threshold as well as S4L and decreased the S5D (P<0.05). Injection of 0.2 ml/kg of the safranal significantly decreased the ADD and S5D (P<0.05) and 83.3% of animals had no stage 4 and stage 5 of kindling (P<0.001). Based on the obtained data safranal has anticonvulsant effects dosedependently. It seems that a dose of 0.2 ml/kg is the minimum effective dose. Further investigation is warranted to conduct the clinical implications for the treatment of epileptic disorders

Quantitative Characterization of the Chemical Space Governed by Human Carbonic Anhydrases and selenium-containing derivatives of solfonamides

Abstract Due to the fact that different isoforms of carbonic anhydrase play distinct physiological roles, their diseases/disorders involvement are different as well. Involvement in major disorders such as glaucoma, epilepsy, Alzheimer's disease, obesity and cancers, have turned carbonic anhydrase into a popular case study in the field of rational drug design. Since carbonic anhydrases are highly similar with regard to their structures, selective inhibition of different isoforms has been a significant challenge. By applying a proteochemometrics approach, herein the chemical interaction space governed by acyl selenoureido benzensulfonamides and human carbonic anhydrases is explored. To assess the validity, robustness and predictivity power of the proteochemometrics model, a diverse set of validation methods was used. The final model is shown to provide valuable structural information that can be considered for new selective inhibitors design. Using the supplied information and to show the applicability of the constructed model, new compounds were designed. Monitoring of selectivity ratios of new designs shows very promising results with regard to their selectivity for a specific isoform of carbonic anhydrase.

Interchangeability among carbamazepine formulations: the impact over epilepsy patients

Abstract The treatment of epilepsy is complex and a matter of concern is the interchangeability among different formulations available for antiepileptic drugs. To evaluate the effects of interchangeability among carbamazepine formulations on patients with epilepsy. This is a prospective cohort study that included adult outpatients diagnosed with epilepsy and under pharmacological treatment with carbamazepine. Before switching the brand/manufacturer, the "Interchangeable Pharmaceutical Product in the Treatment of Epilepsies" questionnaire was applied. The questionnaires "Adverse Events Profile" and Quality of Life in Epilepsy-31, so as the plasma carbamazepine concentrations, were evaluated before and after the brand/ manufacturer switch. Physical-chemical tests aiming to assess tablets quality were performed in accordance with the Brazilian Pharmacopoeia 5th edition. The study population was composed by 14 patients (mean age: 44.6 years), with 10 of females. From those interviewed, 10 had no knowledge about the three antiepileptic drugs formulations available. The frequency of adverse event "problems with skin" incresead (p=0.023) and "upset stomach" decreased (p=0.041) after the changeover. The adverse events profile was associated with only two quality of life domains: "energy/fatigue" (p=0.048) and "total score" (p=0.018). Divergent results between generic and reference formulations were observed in purity-water test (reference: 1.96%, generic: 4.84%) and dissolution test, in which the generic formulation presented 66.27 to 85.77% of carbamazepine dissolved after the third level. Conclusions: Objective differences before and after the brand/manufacturer switch were not observed, in spite of patients' perceptions. Despite that, more studies in the field are necessary, especially on the interchangeability among generic antiepileptics, in order to better elucidate switching consequences on patients' life.

Role of Genetics in the Etiopathogenesis of Genetic Generalized Epilepsy: A Review of Current Literature

"Until recently; genetic generalized epilepsy (GGE) was believed to be of presumed genetic etiology with no identifiable genetic mutation or demonstrable epigenetic abnormality. A wide range of epileptic disorders has clue for an inherited susceptibility. Monogenic disorders associated with epilepsy mental retardation and structural brain lesion typified by heterotopias; tuberous sclerosis; and progressive myoclonus epilepsies account for about 1 of epilepsies. This review focuses on the role of genetic mutations and epigenetic rearrangements in the pathophysiologic mechanism of GGE. To achieve this; PubMed; EMBASE; and Google Scholar were systematically and comprehensively searched using keywords (""epilepsy"" ""juvenile myoclonic epilepsy (JME);"" ""typical absences;"" ""idiopathic generalized epilepsy;"" ""JME;"" ""juvenile absence epilepsy;"" ""childhood absence epilepsy"" ""generalized tonic-clonic seizure"" ""GTCS""). Most GGE has evidence of underlying genetic inheritance. Recent animal studies have shown that early detection and treatment of genetic generalized epilepsies can alter the phenotypic presentation in rodents. These findings suggest a critical period in epileptogenesis; during which spike-and-wave seizures can be suppressed; leading to chronic changes in the brain (epileptogenesis) and the preceding dysfunctions may; therefore; be targeted using therapeutic approaches that may either delay or inhibit the transition to active epileptic attack. The interplay between genetic mutations and epigenetic rearrangements play important roles in the development of GCE and that this process; especially at crucial developmental periods; is very susceptible to environmental modulations"

Inflammatory reaction In epilepsy / Reação inflamatória na epilepsia / Reacción inflamatoria En la epilepsia

Epilepsies are the second most common neurological disease. The pathological mechanisms of this disease are not fully unders- tood. Several studies claim that inflammation plays a significant role both in structural and physiological changes that lead to the emergence of seizures. Although in some epilepsies, such as Rasmussen?s encephalitis, the inflammation has definite importance, in several other epileptic syndromes, the participation of inflammatory reaction still lacks evidence. In such cases, the experimental models are useful for reveal how cytokines, molecules that modulate the inflammatory response, may affect seizures and how seizures may change the expression of these inflammatory molecules. Even with these works, much remains to be clarified with regard to the influence of inflammation on epileptic syndromes. The purpose of this brief review is to discuss the links between inflammatory processes, the origin of crises, and tissue damages in epilepsy.

As epilepsias são a segunda doença neurológica mais frequentes. Os mecanismos patológicos dessa doença ainda não são completamente compreendidos. Vários trabalhos alegam que a inflamação tem um papel importante tanto nas alterações estruturais quanto fisiológicas que levam à geração de crises. Embora em alguns tipos de epilepsia, como a encefalite de Rasmussen, a inflamação tenha importância evidente, em várias outras síndromes epilépticas ainda faltam evidências para confirmar a participação da reação inflamatória. Nesses casos, os modelos experimentais são úteis para revelar como as citocinas, moléculas que modulam a resposta inflamatória, podem afetar as crises e como as crises podem alterar a expressão dessas moléculas inflamatórias. Mesmo com esses trabalhos, muito ainda precisa ser esclarecido com relação à influência da inflamação sobre as síndromes epilépticas. O objetivo desta breve revisão foi discutir as ligações entre os processos inflamatórios, a origem das crises e os danos teciduais na epilepsia.

Las epilepsias son la segunda enfermedad neurológica más común. Los mecanismos patológicos de esta enfermedad no se entienden completamente. Varios estudios afirman que la inflamación juega un papel importante tanto en los cambios estructurales como en los fisiológicos que conducen a la generación de las convulsiones. Aunque en algunos tipos de epilepsia, tales como la encefalitis de Rasmus- sen, la inflamación tiene una importancia evidente, en varios otros síndromes epilépticos todavía carecen de pruebas para confirmar la participación de la reacción inflamatoria. En estos casos, los modelos experimentales son útiles para revelar cómo las citoquinas, molé- culas que modulan la respuesta inflamatoria, pueden afectar a las convulsiones y cómo las convulsiones pueden cambiar la expresión de estas moléculas inflamatorias. Incluso con estos trabajos, queda mucho por aclarar con respecto a la influencia de la inflamación en los síndromes epilépticos. El propósito de esta breve revisión es discutir los vínculos entre los procesos inflamatorios, el origen de la crisis y el daño tisular en la epilepsia.

Development and Evaluation of the Empowering A Self-Efficacy (EASE) Program for Children with Epilepsy

PURPOSE: The purpose of this study was to verify effects of the Empowering A Self-Efficacy (EASE) program on self-efficacy, self-management, and child attitude toward illness in children with epilepsy. METHODS: This was a quasi-experimental study with a non-equivalent control group pre-post test design. Participants were 10 to 15 year old children with epilepsy (11 in the experimental group and 10 in the control group) who were registered at one hospital in S city. The experimental group received the EASE program for 3 weeks. In the first week, a group meeting lasting 570 minutes was conducted on a single day. Over the next two weeks, telephone counselling was conducted twice a week. Data were analyzed using SPSS 18.0. RESULTS: There was a significant difference of pre-post evaluation of the epilepsy self-management scores in the experimental group. However, differences between the experimental group and the control group for seizure self-efficacy and child attitude toward illness were not significant. CONCLUSION: This is the first study in Korea to develop and evaluate an intervention program for children with epilepsy. Further studies are needed to confirm the effects of the EASE program.

John Hughlings Jackson: um neurologista inglês / John Hughlings Jackson: a British neurologist

John Hughlings Jackson tornou-se médico e neurologista por uma via atípica e sem frequentar qualquer universidade. Entretanto, sua mente brilhante e a admirável capacidade de trabalho levaram-no a produzir conhecimentos que repercutem até os dias de hoje, nas áreas do diagnóstico neurológico, epilepsia, localização cerebral, níveis evolucionários do sistema nervoso e sua hierarquia, entre outros. Diversas das condições que descreveu foram designadas com seu nome. É admirável que essa produção médico-científica tenha sido baseada inteiramente na sua aguçada capacidade de observação clínica. Foi a personalidade que mudou a neurologia inglesa, dando-lhe um status que carecia no meio nacional e internacional. É considerado o "pai" da neurologia inglesa.

John Hughlings Jackson became a physician and neurologist through an atypical way, and without attending any university. However, his brilliant mind and amazing capacity for work led him to produce knowledge that resounds until the present days, in areas of neurological diagnosis, epilepsy, brain localization, evolutionary levels of the nervous system and their hierarchies, among others. Several conditions that he described were named after him. It is admirable that this medical-scientyphic production was founded entirely in his sharp ability of clinical observation. He was the personality that changedthe English neurology providing a status it lacked in the national and international milieu. He is considered the "father" of the English neurology.

Investigation of magnetic resonance imaging texture analysis as an aid tool for characterization of refractory epilepsies / Investigacao da analise de textura em imagem de ressonancia magnetica como auxilio para caracterizacao de epilepsias refratarias

Refractory epilepsies are syndromes for which therapies that employ two or more antiepileptic drugs, separately or in association, do not result in control of crisis. Patients may present focal cortical dysplasia or diffuse dysplasia and/or hippocampal atrophic alterations that may not be detectable by a simple visual analysis in magnetic resonance imaging. The aim of this study was to evaluate MRI texture in regions of interest located in the hippocampi, limbic association cortex and prefrontal cortex of 20 patients with refractory epilepsy and to compare them with the same areas in 20 healthy individuals, in order to find out if the texture parameters could be related to the presence of the disease. Of the 11 texture parameters calculated, three indicated the existence of statistically significant differences between the studied groups. Such findings suggest the possibility of this technique contributing to studies of refractory epilepsies.

Epilepsias refratárias compreendem síndromes para as quais as terapias que empregam duas ou mais drogas antiepilépticas, isoladamente ou em associação, não resultam no controle da frequência das crises. Portadores podem apresentar displasias corticais focais ou difusas e/ou alterações atróficas hipocampais que, em alguns casos, não são detectáveis por uma simples análise visual nas imagens de ressonância magnética. Nesse contexto, o objetivo deste estudo foi avaliar a textura de imagens de RM em regiões de interesse localizadas nos hipocampos, córtex de associação límbico e córtex pré-frontal de 20 pacientes com epilepsia refratária e compará-las às mesmas áreas de um grupo de 20 indivíduos sadios. Dos 11 parâmetros de textura calculados, três indicaram a existência de diferenças estatisticamente significantes entre os grupos estudados. Tais achados sugerem a possibilidade desta técnica contribuir para os estudos das epilepsias de difícil controle.

Tumor neuroepitelial disembrioplásico: presentación de caso y revisión de la literatura / Dysembryoplastic Neuroepithelial Tumor (DNT): Case Presentation and Literature Review

El tumor neuroepitelial disembrioplásico (DNT) fue descrito por primera vezpor Daumas-Duport, en 1988, e incorporado a la clasificación de tumores de laOrganización Mundial de la Salud, desde 1993, como parte del grupo de tumoresneurogliales. El artículo describe un caso típico, dada su presentación clínica, hallazgosimaginólógicos e histológicos, con adecuada evolución postoperatoria. Se haceuna revisión de la literatura del DNT, describiendo su epidemiología, presentaciónclínica, hallazgos imaginólógicos e histológicos, posibilidades de tratamiento actualy pronóstico...

Dysembryoplastic neuroepithelial tumors (DNT)were first described by Daumas-Duport in 1988and incorporated into the new World Health Organizationclassification of brain tumours as partof the group of glioneuronal tumours in 1993. Wedescribe a typical case due to its clinical presentation,image and hystologic findings, with goodpostoperative course. A review of the literatureof DNT is made, describing its epidemiology,clinical presentation, image and histological findings,current treatment options and prognosis...

Usefulness of Diffusion Tensor Tractography in Pediatric Epilepsy Surgery

PURPOSE: This study was conducted to assess the clinical relevance of diffusion tensor tractography (DTT) in pre- and post-operative evaluations of childhood epilepsy surgery. MATERIALS AND METHODS: Seventy-two patients who received epilepsy surgery between March 2004 and July 2008 were retrospectively analyzed (M : F=40 : 32, ages of 3 months to 24 years, mean age=8.9 years). DTT was performed using a 3.0 T scanner and single-shot spin-echo echo-planar imaging with 32-different diffusion gradient directions. We reviewed the data focusing on the type of surgery, final pathological diagnosis, and how the DTT data were clinically used. RESULTS: The most common form of childhood epilepsy surgery was complete resection of an epileptogenic lesion (n=52, 72.2%). The reported etiologies included cortical dysplasia (n=32, 44.4%), hippocampal sclerosis (n=9, 12.5%), brain tumors (n=7, 9.7%), and non-pathologic lesions (n=4, 5.6%) in the final diagnoses. Twenty-one dysplastic cortexes and four brain tumors involved an approximal relationship with the corticospinal tract (n=18), optic radiation (n=2), and arcuate fasciculus (n=5). Additionally, although DTT demonstrated white matter tracts clearly, DTT in the hippocampal sclerosis did not provide any additional information. In cases of callosotomy (n=18, 25%), post-operative DTT was utilized for the evaluation of complete resection in all patients. DTT information was not used in functional hemispherectomy (n=2, 2.8%). CONCLUSION: Preoperatively, DTT was a useful technique in cases of cortical dysplasia and brain tumors, and in cases with callosotomy, postoperatively. DTT should be included among the routine procedures performed in management of epilepsy.

Manifestaciones psiquiátricas en epilepsia / Psychiatric manifestations in epilepsy

La Organización Mundial de la Salud (OMS) y la Liga Internacional contra la Epilepsia (ILAE), la definen como una afección neurológica crónica, recurrente y repetitiva de fenómenos paroxíticos, ocasionados por descargas neuronales desorganizadas y excesivas. La epilepsia es la condición neurológica más seria y más común. Se estima que la prevalencia actual del trastorno es de 5-10/1000 personas; excluyendo a las convulsiones febriles, los casos de una crisis única y los casos inactivos. Sus causas pueden ser muy diversas y sus manfiestaciones muy variadas, de esta manera su sintomatología se ubica dentro de un polimorfismo acentuado. Dentro de las posibles manfiestaciones clínicas que pueden presentarse, se encuentran aquellas en las que predominan las alteraciones conductuales. El objetivo de la presente revisión es el poder dar cuenta de la presentación de los síntomas psiquiátricos en epilepsia, el impacto de estos y la importancia del manejo interdisciplinario con neurólogos. El reconocimiento de estos cuadros resulta de suma importancia en la práctica de la interconsulta, dada la implicancia de los profesionales de salud mental en el manejo sintomático de dichas manifestaciones.

The World Health Organization (WHO) and the International League Against Epilepsy (ILAE) define epilepsy as a chronic neurological affection, characterized by recurrent and repetitive paroxysmal phenomena generated by disorganized and excessive neuronal discharges. Epilepsy is the most serious and frequent neurological condition. It is estimated that its current prevalence is 5-10/1,000 people; excluding febrile seizures, single seizures and inactive cases. Because its causes and manifestations can be very varied, its symptomatology is placed with in a marked polymorphism. Among the possible clinical manifestations that may appear are those in which behavioral alterations prevail. The aim of this review is to describe the onset of psychiatric symptoms in epilepsy, their impact and the importance of interdisciplinary management of this disease with Neurologists. Identifying these clincal symptoms is of the utmost importance, given the involvement of healthcare profesionals in the symptomatic treatment of those manifestations.

The Localizing and Lateralizing Value of Auras in Lesional Partial Epilepsy Patients

PURPOSE: We investigated the localizing and lateralizing values of auras in patients with lesional partial epilepsy on an outpatient basis. MATERIALS AND METHODS: A total of 276 subjects were retrospectively selected for this study if they had a unilateral single lobar lesion based on magnetic resonance image (MRI) results, and their scalp electroencephalography (EEG) findings were not discordant with the MRI-defined lobar localization and lateralization. According to the lesion locations, subjects were considered as having mesial temporal (MTLE), lateral temporal (LTLE), frontal (FLE), parietal (PLE), or occipital (OLE) lobe epilepsies. Auras were classified into 13 categories. RESULTS: A hundred and seventy-six subjects (63.8%) had experienced at least one aura. FLE subjects had the fewest number of auras. Epigastric and psychic auras were frequent among MTLE subjects, while visual auras were common in those with PLE and OLE. Somatosensory auras and whole body sensations were more frequent in the subjects with PLE than those without. Autonomic auras were more common in MTLE subjects than in LTLE subjects. Dysphasic auras were more frequently found in left-sided epilepsies. Five pairs of aura categories showed concurrent tendencies, which were the epigastric and autonomic auras, autonomic and emotional auras, visual and vestibular auras, auditory and vestibular auras, and whole-body sensation and auditory auras. Autonomic and emotional auras had a concurrent tendency in left-sided epilepsies, but not in right-sided epilepsies. CONCLUSION: Our results support the previously known localizing value of auras, and suggest that dysphasic auras and the association of emotional and autonomic auras may have a lateralizing value.

Neuroprotective effect of vitamin c against ptz induced apoptotic neurodegeneration in adult rat brain

The present study was designed to observe the effect of PTZ on expression of caspsae-3, and to evaluate the neuroprotective role of vitamin C [vit-C] against PTZ-induced apoptotic neurodegeneration in adult rat brain. We observed that administration of a single conclusive dose of pentylenetetrazol [PTZ 50mg/kg] in adults rats induced epileptic seizure and increased activation of caspase-3 and caused neuronal death. Further, rats were injected with vit-C [250 mg/kg] 30 min before PTZ injection. The protective effect of vit-C against PTZ-induced apoptotic neurodegeneration in adult rat brain was observed using Western blot analysis and Nissl staining. The results showed that conclusive dose of PTZ-induced seizure, increased expression of caspase-3 and neuronal apoptosis in adult rat brain. Whereas, the pretreatment of vit-C along with PTZ showed significantly decreased expression of caspase-3 as compare to control group. Finally, our results indicated that vit-C can prevent some of the deleterious effect of seizure and neuronal degeneration induced by PTZ in adult rat brain

Células-tronco mesenquimais derivadas da polpa de dente humano: caracterização e estudos funcionais em modelo experimental de epilepsia / Mesenchymal stem cells derived from human tooth pulp: characterization and functional studies in an experimental model of epilepsy

Terapia celular é o conjunto de métodos e abordagens tecnológicas com a utilização de células no tratamento de doenças. A terapia com células-tronco tem despertado grande interesse na comunidade científica devido à capacidade que essas células indiferenciadas têm de preservar sua própria população e de se diferenciar em células dos diversos tecidos. Encontrar a fonte de célula-tronco apropriada para uso terapêutico depende de diversos fatores, como a sua capacidade de proliferação e estabilidade citogenética, assim como suas características fenotípicas e seu potencial de diferenciação. A epilepsia é uma desordem neurológica que acomete de 1 a 3% da população mundial. É caracterizada pela presença de crises espontâneas recorrentes (CER) e possui seu tratamento clínico baseado no emprego de drogas anti-epilépticas (DAES). O uso de células tronco apresenta-se como uma alternativa ao tratamento desta patologia. Este trabalho tem como objetivos caracterizar as células-tronco mesenquimais de polpa de dente decíduo humano e avaliar seu papel terapêutico no modelo de epilepsia do lobo temporal induzido por lítio-pilocarpina em ratos Wistar. As células da polpa de dente humano utilizadas nesse estudo foram submetidas à avaliação fenotípica, do seu potencial de diferenciação, e da estabilidade cromossômica. Para verificar os efeitos terapêuticos das células-tronco de polpa de dente em modelo experimental de epilepsia os animais foram divididos nos seguintes grupos: SE-salina (n=10), que no transplante recebeu solução salina; SE-CDLH1 (n=13) que recebeu células-tronco de polpa de dente humano (107 células/animal), SE-CMO (n=8) que recebeu células mononucleares de medula óssea (107 células/animal) e o grupo controle (n=10) que não foi submetido ao status epilepticus (SE). As células foram transplantadas por via intraperitoneal. Foram realizadas análises, em diferentes espaços de tempo para avaliar migração celular por imunofluorescência e as crises espontâneas recorrentes. Para avaliar alterações de memória foi estudado o desempenho dos animais no labirinto aquático de Morris (LAM). As CDLH1 apresentaram estabilidade cromossômica (até a 8ª passagem); características imunofenotípicas de células mesenquimais, com alta expressão de CD105, CD73, CD 44, CD90, CD166, CD54, OCT-4, e STRO-1; capacidade de diferenciação nas linhagens adipogênicas, osteogênicas e condrogênicas. As CDLH1 migraram para o cérebro e baço dos ratos. Dos resultados terapêuticos observou-se a redução das crises espontâneas recorrentes nos animais tratados após 30 dias do SE e transplante, mas as células não foram capazes de bloquear essas crises (observado 60 dias pós-SE). Obtendo-se os mesmos resultados com o transplante de CMO. Já no estudo da memória não houve diferença estatística na latência de escape nos animais dos grupos epilépticos tratado e não-tratado). Os animais do grupo controle (não epiléptico), apresentaram retenção de memória em relação aos animais dos grupos SE-salina e SE-CDLH1. Novos estudos devem ser realizados para que se possa estabelecer a utilização ideal das células-tronco mesenquimais derivadas da polpa de dente humano em relação às necessidades terapêuticas da epilepsia.

Neuronal damage and memory deficits after seizures are reversed by ascorbic acid? / O dano neuronal e o déficit de memória após convulsões são revertidos pelo ácido ascórbico?

The objective of the present study was to evaluate the neuroprotective effects of ascorbic acid (AA) in rats, against the neuronal damage and memory deficit caused by seizures. Wistar rats were treated with 0.9 percent saline (i.p., control group), ascorbic acid (500 mg/kg, i.p., AA group), pilocarpine (400 mg/kg, i.p., pilocarpine group), and the association of ascorbic acid (500 mg/kg, i.p.) plus pilocarpine (400 mg/kg, i.p.), 30 min before of administration of ascorbic acid (AA plus pilocarpine group). After the treatments all groups were observed for 24 h. Pilocarpine group presented seizures which progressed to status epilepticus in 75 percent of the animals. Pretreatment with AA led to a reduction of 50 percent of this rate. Results showed that pretreatment with AA did not alter reference memory when compared to a control group. In the working memory task, we observed a significant day's effect with important differences between control, pilocarpine and AA plus pilocarpine groups. Pilocarpine and AA plus pilocarpine groups had 81 and 16 percent of animals with brain injury, respectively. In the hippocampus of pilocarpine animals, it was detected an injury of 60 percent. As for the animals tested with AA plus pilocarpine, the hippocampal region of the group had a reduction of 43 percent in hippocampal lesion. Our findings suggest that seizures caused cognitive dysfunction and neuronal damage that might be related, at least in part, to the neurological problems presented by epileptic patients. AA can reverse cognitive dysfunction observed in rats with seizures as well as decrease neuronal injury in rat hippocampus.

O objetivo do presente estudo foi avaliar o efeito neuroprotetor do ácido ascórbico (AA), contra o dano neuronal e o déficit de memória em ratos causados pelas convulsões. Ratos Wistar foram tratados com solução salina a 0,9 por cento (i.p., grupo controle), ácido ascórbico (500 mg/kg, i.p., grupo AA), pilocarpina (400 mg/kg, i.p., grupo pilocarpina), e a associação de ácido ascórbico (500 mg/kg, i.p.) com pilocarpina (400 mg/kg, i.p.), 30 min após a administração de ácido ascórbico (AA + pilocarpina grupo). Após os tratamentos todos os grupos foram observados durante 24 h. O grupo pilocarpina apresentou crises convulsivas que evoluíram para o estado de mal epiléptico em 75 por cento dos animais. O pré-tratamento com AA produz uma redução de 50 por cento nesta taxa. Os resultados mostraram que o pré-tratamento com AA não alterou a memória em relação ao controle. No teste de memória, observou-se um efeito significativo nos dias avaliados entre os grupos controle, pilocarpina e AA + pilocarpina. 81 e 16 por cento dos animais dos grupos AA + pilocarpina e pilocarpina apresentaram danos cerebrais, respectivamente. No hipocampo dos animais do grupo pilocarpina, que foi detectada uma lesão de hipocampal de 60 por cento. Quanto aos animais do grupo AA + pilocarpina, a região do hipocampo apresentou uma redução de 43 por cento na extensão da lesão no hippocampo. Nosso resultados sugerem que as convulsões produzem disfunção cognitiva e dano neuronal que podem estar relacionados, pelo menos em parte, aos problemas neurológicos apresentados pelos pacientes epilépticos. O ácido ascórbico pode reverter essa disfunção cognitiva observado em ratos convulsivos, bem como reduz o desenvolvimento da lesão neuronal no hipocampo de ratos.

Morphology changes of ubiquitin-proteasome system in traumatic epilepsy / 法医学杂志

OBJECTIVE@#To investigate the value of ubiquitin(Ub) and ubiquitin-activating enzymel(UbE1) for the appraisement of post traumatic epilepsy (PTE).@*METHODS@#Fifteen specimens from human epileptic temporal cortex originating from PTE were collected as the PTE group. Fifteen specimens from non-PTE were collected as the non-PTE group. Meanwhile, 15 normal cerebral cortex specimens from people dead from acute traffic accident were collected as the control groups. Observe morphology changes of each group with HE, then with immunohistochemistry of Ub and UbE1.@*RESULTS@#Compared to the control group, morphology changes of neuron quantity reduction, neuron denaturation and so on were observed both in the PTE group and the non-PTE group under HE, especially in the PTE group. Ub and UbE1 mainly expressed in the nucleus and cytoplasm of the neurons in epilepsy spot without extracellular expression. The expression of Ub and UbE1 is PTE group > non-PTE group > control group (P < 0.05).@*CONCLUSIONS@#The neuron denaturation are one of the main pathology changes of epilepsy, and it is more obvious in the PTE group. Immunohistochemistry of Ub and UbE1 may be more helpful to distinguish PTE and non-PTE than HE staining.

Seizure-Like Activities during Head-Up Tilt Test-Induced Syncope

PURPOSE: Some patients with neurally mediated reflex syncope may be misdiagnosed as epilepsy because myoclonic jerky movements are observed during syncope. The seizure-like activities during the head-up tilt test (HUT) have been rarely reported. The purpose of this study was to assess the characteristics of these seizure-like activities and evaluate whether there are differences in the clinical characteristics and hemodynamic parameters of patients with neurally mediated reflex syncope with and without seizure-like activities during HUT-induced syncope. MATERIALS AND METHODS: The medical records of 1,383 consecutive patients with a positive HUT were retrospectively reviewed, and 226 patients were included in this study. RESULTS: Of 226 patients, 13 (5.75%) showed seizure-like activities, with 5 of these (2.21%) having multifocal myoclonic jerky movements, 5 (2.21%) having focal seizure-like activity involving one extremity, and 3 (1.33%) having upward deviation of eye ball. Comparison of patients with and without seizure-like activities revealed no significant differences in terms of clinical variables and hemodynamic parameters during HUT. CONCLUSION: Seizure-like activities occurred occasionally during HUT-induced syncope in patients with neurally mediated reflex syncope. The seizure-like activities during HUT might not be related to the severity of the syncopal episodes or hemodynamic changes during HUT.